Franklin Resources’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $233M | Sell |
|
|||||
2025
Q1 | $340M | Sell |
|
|||||
2024
Q4 | $306M | Buy |
|
|||||
2024
Q3 | $231M | Sell |
|
|||||
2024
Q2 | $259M | Sell |
|
|||||
2024
Q1 | $294M | Buy |
|
|||||
2023
Q4 | $274M | Sell |
|
|||||
2023
Q3 | $262M | Sell |
|
|||||
2023
Q2 | $293M | Buy |
|
|||||
2023
Q1 | $241M | Sell |
|
|||||
2022
Q4 | $229M | Sell |
|
|||||
2022
Q3 | $270M | Sell |
|
|||||
2022
Q2 | $279M | Sell |
|
|||||
2022
Q1 | $294M | Buy |
|
|||||
2021
Q4 | $233M | Buy |
|
|||||
2021
Q3 | $157M | Sell |
|
|||||
2021
Q2 | $226M | Sell |
|
|||||
2021
Q1 | $250M | Sell |
|
|||||
2020
Q4 | $303M | Buy |
|
|||||
2020
Q3 | $325M | Buy |
|
|||||
2020
Q2 | $333M | Buy |
|
|||||
2020
Q1 | $260M | Sell |
|
|||||
2019
Q4 | $251M | Sell |
|
|||||
2019
Q3 | $211M | Buy |
|
|||||
2019
Q2 | $198M | Sell |
|
|||||
2019
Q1 | $213M | Sell |
|
|||||
2018
Q4 | $201M | Sell |
|
|||||
2018
Q3 | $238M | Sell |
|
|||||
2018
Q2 | $219M | Buy |
|
|||||
2018
Q1 | $184M | Sell |
|
|||||
2017
Q4 | $187M | Buy |
|
|||||
2017
Q3 | $176M | Buy |
|
|||||
2017
Q2 | $147M | Sell |
|
|||||
2017
Q1 | $131M | Sell |
|
|||||
2016
Q4 | $107M | Buy |
|
|||||
2016
Q3 | $121M | Buy |
|
|||||
2016
Q2 | $88.2M | Buy |
|
|||||
2016
Q1 | $78.7M | Buy |
|
|||||
2015
Q4 | $110M | Buy |
|
|||||
2015
Q3 | $85.2M | Sell |
|
|||||
2015
Q2 | $144M | Buy |
|
|||||
2015
Q1 | $112M | Sell |
|
|||||
2014
Q4 | $114M | Sell |
|
|||||
2014
Q3 | $126M | Sell |
|
|||||
2014
Q2 | $139M | Sell |
|
|||||
2014
Q1 | $125M | Buy |
|
|||||
2013
Q4 | $114M | Buy |
|
|||||
2013
Q3 | $106M | Buy |
|
|||||
2013
Q2 | $104M | Buy |
|